Pharma Industry
Latest News
Advertisement
Latest Videos
Shorts
0:44
A pharmacy benefit model built to cut prior authorization
2 days ago
by
Jay Bregman
0:59
Is insurance actually the best deal?
2 days ago
by
Joseph Kleiman
1:11
Why GLP-1s broke pharmacy coverage
3 days ago
by
Jay Bregman
0:37
Help for burnt-out doctors
9 days ago
by
Joseph Kleiman
1:13
Medicare and Medicaid's GLP-1 programs: A real split or a distinction without a difference?
12 days ago
by
Tracy Zvenyach, Ph.D., M.S., R.N.
1:00
Why patients are walking away from health care
12 days ago
by
Dean Erhardt
0:43
Patients are becoming the CEOs of their health care
16 days ago
by
Dean Erhardt
0:43
Why do patients abandon prescriptions?
16 days ago
by
Joseph Kleiman
0:30
Stop wasting time on prior authorizations
19 days ago
by
Dean Erhardt
0:57
Location, location, location: U.S. health care's geography problem
22 days ago
by
Dean Erhardt
Podcasts
Advertisement
More News
Because clinicians and the system are not programmed to ask: What can safely be stopped?
There needs to be conversations about pricing and fulfillment options at the point of prescribing, so patients can compare pricing and make an informed decision.
The top news stories in medicine this week.
Did you know that 45% of Americans misread their drug labels?
The top news stories in medicine this week.
Access, affordability, ambiguity: Who really benefits from federal prescription drug price policies?
A policy expert explains what physicians need to know when patients ask about the changing prices of their medicines.
But some of the state’s top physicians and clinicians say they were blindsided by the pilot program.
The top news stories in medicine this week.
When it comes to filling prescriptions, having a nearby pharmacy isn't always enough.
Everyday prescriptions such as atorvastatin, lisinopril and metformin are now on the federal price comparison site, though experts say insured patients still may pay less through their plans.
Here’s how three states used Medicaid policies to cut costs and improve accountability by reining in pharmacy benefit managers
No physician wants to write a prescription that their patient can’t afford. But having affordability information, such as co-pays and vouchers or discounts, embedded into the EHR encourages better conversations between patients and providers about medication costs and support options.
The sad reality is that too many Americans are ingesting a daily cocktail of Big Pharma prescribed by multiple doctors who typically don’t talk to each other or know each other.
What physicians need to know about a massive program that affects prices of medicines.
Medicare has a laudable goal to bargain for lower prices, but there’s a chance patients could lose out on billions in savings.
Vaccines, autism are part of Senate questioning as Casey Means, M.D., says she supports physicians and patients making decisions rather than depending on surgeon general pronouncements.
Trump spotlights drug-price transparency and Most Favored Nation pricing —signaling changes to Obamacare subsidies and hospital insurer rules.
Advertisement
Advertisement
Trending on Medical Economics
1
How value-based payment models are reshaping physician practices — and what comes next
2
Why independent practices need to see their market before signing another lease
3
Can AI rescue physicians from Medicare's documentation arms race?
4
If it wasn't done, don't chart it: A warning on EHR template overuse and fraud
5